PB2044: FINAL PATIENT-REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOG...

por Hartford, Christopher, Nguyen, Quang P., Sherman, Steven, Pavani, Rodrigo, Aurand, Lisa, Rofail, Diana, Kelly, Richard
Publicado 2023

P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

por Jang, Jun-Ho, Wong, Raymond, Pavani, Rodrigo, Aurand, Lisa, Nguyen, Quang P., Perlee, Lorah, Souttou, Amal, Weyne, Jonathan, Kelly, Richard
Publicado 2023

P797: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF COMBINATION POZELIMAB AND CEMDISIRAN THERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO SWITCH...

por Kelly, Richard, Houghton, Nicola, Munir, Talha, Muus, Petra, Youngs, Nora, Aurand, Lisa, Senk, Brian, Pavani, Rodrigo, Perlee, Lorah, Souttou, Amal, Griffin, Morag
Publicado 2023